The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study
Abstract
The presence of persister cells and small-colony variants (SCVs) has been associated with enhanced antibiotic resistance of many organisms in biofilms. This study investigated whether persisters and/or SCVs contribute to the antibiotic resistance of Staphylococcus aureus biofilms. A detailed dose-dependent killing of biofilms and planktonic cells with five antibiotics (oxacillin, cefotaxime, amikacin, ciprofloxacin and vancomycin) was analysed by treating them with each antibiotic at a concentration of 0–100 μg ml−1 at 37 °C for 48 h. The killing of biofilm cells by all of the antibiotics showed the presence of persister cells – most cells in the population died, leaving a fraction that persisted, even at higher concentrations of the antibiotics. These persisters represented a transient resistant phenotype and reverted to a killing curve resembling that of the wild-type parent upon re-exposure to the antibiotics. SCVs were observed in biofilms only after treatment with ciprofloxacin, and these SCVs were of a transient nature. The treatment of planktonic cells with oxacillin, cefotaxime, ciprofloxacin and vancomycin killed the entire population and no persisters were detected. Transient SCVs, observed in planktonic cells following exposure to these antibiotics, were killed at higher antibiotic concentrations. The treatment of planktonic cells with amikacin yielded a small subpopulation of survivors that included persisters (at numbers significantly lower than for the biofilms) and highly resistant, stable SCVs with an increased biofilm-forming capacity in comparison with the wild-type parent. Thus the high resistance of S. aureus biofilms to multiple unrelated antibiotics is largely dependent on the presence of persister cells. Biofilms harbour a large number of persisters in comparison with planktonic cultures, which either do not harbour persisters or harbour only a small number. SCVs, although not specifically associated with S. aureus biofilms, have an increased biofilm-forming capacity and this may explain the frequent isolation of SCVs from biofilm-associated infections. The intrinsic resistance of these variants may in turn contribute to the enhanced antibiotic resistance of the biofilms thus formed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 2×
“Staphylococcus aureus biofilms have been widely implicated in many implant-based and chronic infections including those associated with prosthetic heart valves, central venous catheters, urinary catheters, orthopaedic prostheses, penile prostheses and contact lenses, endocarditis, otitis media, osteomyelitis and sinus…”
BackgroundAntibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
The estimation of the bactericidal power of the blood
Miles, A. A., Misra, S. S., & Irwin, J. O. (1938) · Epidemiology and Infection · doi:10.1017/s002217240001158x · Cited by 3,583
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 2×
“1–10 %) persisting, even on prolonged exposure (Balaban et al., 2004; Keren et al., 2004a) or at higher concentrations of the antibiotics (Brooun et al.”
BackgroundManual of clinical microbiology
Drasar, B. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)90074-5 · Cited by 2,594
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 1×
“Moreover, planktonic persisters, even if they exist, are liable to be eliminated by the immune system in vivo, whereas biofilm persisters are protected by the exopolysaccharide matrix (Lewis, 2007).”
BackgroundSurvival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997
Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Anderl, J. N., Franklin, M. J., & Stewart, P. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1818-1824.2000 · Cited by 958 · cited 1×
“The method of Anderl et al. (2000) was followed to prepare colony biofilms.”
MethodSpoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 856
Impact of the agr Quorum‐Sensing System on Adherence to Polystyrene in Staphylococcus aureus
Vuong, C., Saenz, H. L., Götz, F., & Otto, M. (2000) · The Journal of Infectious Diseases · doi:10.1086/317606 · Cited by 499
A Dose-Response Study of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
Brooun, A., Liu, S., & Lewis, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.640-646.2000 · Cited by 473
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
Gilbert, P., Allison, D. G., & McBain, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.5.x · Cited by 323
Bendouah, Z., Barbeau, J., Hamad, W. A., & Desrosiers, M. (2006) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.03.001 · Cited by 279
Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro
Amorena, B., Gracia, E., Monzón, M., Leiva, J., Oteiza, C., Pérez, M., Alabart, J.-L., & Hernández-Yago, J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.43 · Cited by 247
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection
Häußler, S., Ziegler, I., Löttel, A., Götz, F. V., Rohde, M., Wehmhöhner, D., Saravanamuthu, S., Tümmler, B., & Steinmetz, I. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05069-0 · Cited by 228
Staphylococcal Small Colony Variants Have Novel Mechanisms for Antibiotic Resistance
Proctor, R. A., Kahl, B., von Eiff, C., Vaudaux, P. E., Lew, D. P., & Peters, G. (1998) · Clinical Infectious Diseases · doi:10.1086/514906 · Cited by 204
Characterization of Colony Morphology Variants Isolated from Streptococcus pneumoniae Biofilms
Allegrucci, M., & Sauer, K. (2007) · Journal of Bacteriology · doi:10.1128/jb.01369-06 · Cited by 174
Biofilms, Infection, and Antimicrobial Therapy
(2005) · CRC Press eBooks · doi:10.1201/9781420028232 · Cited by 165
Besier, S., Smaczny, C., von Mallinckrodt, C., Krahl, A., Ackermann, H., Brade, V., & Wichelhaus, T. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01510-06 · Cited by 164
Small Colony Variants in Staphylococcal Infections: Diagnostic and Therapeutic Implications
Proctor, R. A., & Peters, G. (1998) · Clinical Infectious Diseases · doi:10.1086/514706 · Cited by 160
Modelling protection from antimicrobial agents in biofilms through the formation of persister cells
Roberts, M. E., & Stewart, P. S. (2005) · Microbiology · doi:10.1099/mic.0.27385-0 · Cited by 150
The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus
Williams, I., Venables, W. A., Lloyd, D., Paul, F., & Critchley, I. A. (1997) · Microbiology · doi:10.1099/00221287-143-7-2407 · Cited by 144
Chuard, C., Vaudaux, P. E., Proctor, R. A., & Lew, D. P. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.5.603 · Cited by 123
Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli
Ashby, M. J., NEALE, J. E., KNOTT, S. J., & Critchley, I. A. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.3.443 · Cited by 117
Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus
Acar, J. F., Goldstein, F. W., & Lagrange, P. (1978) · Journal of Clinical Microbiology · doi:10.1128/jcm.8.2.142-147.1978 · Cited by 73 · cited 2×
“They differ from the normal phenotype in their small colony size, reduced growth rate, pigmentation and haemolysis, altered expression of virulence factors and auxotrophy for haemin, menadione, thiamine or thymidine, and they are more resistant to the action of aminoglycosides and cell-wall inhibitors and have a tende…”
BackgroundBayston, R., Ashraf, W., & Smith, T. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm031 · Cited by 67
The growth of Gardnerella vaginalis and Lactobacillus acidophilus in Sorbarod biofilms
Muli, F. W., & Struthers, J. K. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-5-401 · Cited by 23
Persisters: Specialized Cells Responsible for Biofilm Tolerance to Antimicrobial Agents
Lewis, K., Spoering, A. L., Kaldalu, N., Keren, I., & Shah, D. (2005) · CRC Press eBooks · doi:10.1201/9781420028232-18 · Cited by 17
Staphylococcus aureus Biofilms
Sullam, P. M., & Higashi, J. M. (2005) · CRC Press eBooks · doi:10.1201/9781420028232.ch6 · Cited by 14
Cited by
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Multi-species biofilms: living with friendly neighbors
Elias, S., & Banin, E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00325.x · Cited by 762
Staphylococcus aureus biofilms: recent developments in biofilm dispersal
Lister, J. L., & Horswill, A. R. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00178 · Cited by 706
Bacterial Persister Cell Formation and Dormancy
Wood, T. K., Knabel, S. J., & Kwan, B. W. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02636-13 · Cited by 703
Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions
Kavanagh, N., Ryan, E. J., Widaa, A., Sexton, G., Fennell, J., O'Rourke, S., Cahill, K. C., Kearney, C. J., O'Brien, F. J., & Kerrigan, S. W. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-17 · Cited by 547
Metadata
- Authors
- Singh, R., Ray, P., Das, A., & Sharma, M.
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2009-08-01
- Volume
- 58
- Issue
- 8
- Pages
- 1067-1073
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- OpenAlex
- W2059780464
- Cited by
- 262
- References
- 38
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.